Literature DB >> 1356091

The effect of dopamine on rat gastric motility.

Y Nagahata1, T Urakawa, H Kuroda, K Tomonaga, H Idei, N Kawakita, K Yoshizumi, Y Saitoh.   

Abstract

The inhibitory mechanism of dopamine (DA) on rat gastric motility was investigated in association with DA receptors. Gastric movement was assessed according to the method of Jacoby et al and was expressed with the system of Ludwick et al. (1968). DA inhibited gastric movement in both the corpus and antrum in a dose-dependent manner. Domperidone, a specific antagonist of DA2 receptor, suppressed DA-induced inhibition of gastric movement in a dose-dependent manner. SCH23390, a specific antagonist of DA1 receptor did not affect DA-induced inhibition of gastric movement. LY171555, a specific agonist of DA2 receptor, inhibited gastric movement in both the corpus and antrum in a dose-dependent manner. SKF38393, a specific agonist of DA1 receptor, did not affect gastric movement. These results indicate that DA plays an important role in the inhibitory regulation of gastric motility, through DA2 receptor but not DA1 receptor.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1356091     DOI: 10.1007/bf02777783

Source DB:  PubMed          Journal:  Gastroenterol Jpn        ISSN: 0435-1339


  29 in total

1.  Attenuation of dopamine renal and mesenteric vasodilation by haloperidol: evidence for a specific dopamine receptor.

Authors:  B K Yeh; J L McNay; L I Goldberg
Journal:  J Pharmacol Exp Ther       Date:  1969-08       Impact factor: 4.030

2.  [Inhibitory mechanism of dopamine on rat gastric motility--in association with acetylcholine release].

Authors:  M Nakamoto; T Urakawa; Y Saitoh
Journal:  Nihon Shokakibyo Gakkai Zasshi       Date:  1987-03

Review 3.  Pathogenesis of duodenal ulcer disease.

Authors:  S Szabo
Journal:  Lab Invest       Date:  1984-08       Impact factor: 5.662

Review 4.  Peripheral dopaminergic receptors. Physiological and pharmaceutical aspects of therapeutic importance.

Authors:  J M van Rooyen; J Offermeier
Journal:  S Afr Med J       Date:  1981-03-07

5.  3H-Domperidone: a selective ligand for dopamine receptors.

Authors:  M Baudry; M P Martres; J C Schwartz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1979-09       Impact factor: 3.000

6.  [Effects of dopamine on stress ulcer].

Authors:  Y Nagahata; T Urakawa; H Moritomo; T Ichihara; A Itoh; K Takeda; H Kuroda; H Idei; K Tomonaga; Y Saitoh
Journal:  Nihon Shokakibyo Gakkai Zasshi       Date:  1990-06

7.  On the ability of domperidone to selectively inhibit catecholamine-induced relaxation of circular smooth muscle of guinea-pig stomach.

Authors:  H A Sahyoun; B Costall; R J Naylor
Journal:  J Pharm Pharmacol       Date:  1982-01       Impact factor: 3.765

8.  Effect of dopamine on pentagastrin-stimulated gastric antral motility in dogs with gastric fistula.

Authors:  K Bech; C P Hovendal; D Andersen
Journal:  Scand J Gastroenterol       Date:  1982-01       Impact factor: 2.423

9.  Dopaminergic and beta-adrenergic effects on gastric antral motility.

Authors:  K Bech; C P Hovendal; F Gottrup; D Andersen
Journal:  Scand J Gastroenterol Suppl       Date:  1984

10.  Effects of KW-5338 (domperidone) on gastric motility.

Authors:  K Shuto; S Shiozaki; T Kojima; M Tanaka
Journal:  J Pharmacobiodyn       Date:  1980-12
View more
  1 in total

Review 1.  DA-9701: A New Multi-Acting Drug for the Treatment of Functional Dyspepsia.

Authors:  Yong Sam Kwon; Miwon Son
Journal:  Biomol Ther (Seoul)       Date:  2013-05-30       Impact factor: 4.634

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.